Hodgkins Lymphoma Clinical Trial
This study is designed to test: 1. in patients with negative positron-emission tomography (PET) after 2 cycles of BEACOPPesc chemotherapy: whether the number of cycles can be reduced without compromising progression free survival (PFS) (2 further cycles vs. 6 further cycles) 2. for patients with positive PET after 2 cycles: whether intensifying BEACOPPesc chemotherapy by adding Rituximab improves PFS.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00383097 -
Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma
|
Phase 1 | |
| Completed |
NCT01517581 -
Brown Fat Activity and White Fat Accumulation
|
N/A | |
| Terminated |
NCT01326728 -
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
|
||
| Completed |
NCT00837200 -
Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
|
Phase 2 | |
| Terminated |
NCT02603419 -
Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)
|
Phase 1 | |
| Active, not recruiting |
NCT02099266 -
Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment
|
N/A | |
| Completed |
NCT02057445 -
3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma
|
Phase 1 | |
| Terminated |
NCT01636388 -
Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma
|
Phase 2 | |
| Terminated |
NCT01300611 -
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
|
Phase 1 | |
| Completed |
NCT01014507 -
Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
|
Phase 2 | |
| Enrolling by invitation |
NCT00923442 -
Biology Studies of Hematologic Cancers
|
||
| Terminated |
NCT00973804 -
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
|
Phase 1 | |
| Completed |
NCT00739141 -
Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
|
Phase 2 | |
| Recruiting |
NCT05134740 -
(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL).
|
Phase 1 | |
| Completed |
NCT01572662 -
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
|
Phase 2 |